GlassScriptPhysician profile
Yoram Hahn
NPI 1275528697
$813.54
in general payments reported to CMS, 2019-2025
19 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $187 · 2020: $11.76 · 2021: $307 · 2022: $191 · 2023: $117.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $117.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $116.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $187.03 | 2021-2023 | Prolia, Evenity |
| Abbvie INC. | $144.51 | 2019-2022 | |
| Daiichi Sankyo INC. | $83.25 | 2021-2022 | |
| Hologic Sales and Service, LLC | $53.47 | 2019-2023 | Aptima, Thinprep 2000 Processor, Third Wave |
| Avion Pharmaceuticals | $47.22 | 2021-2023 | Balcoltra |
| Merck Sharp & Dohme LLC | $38.61 | 2019-2020 | |
| Myovant Sciences INC. | $37.73 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $26.71 | 2019-2021 | |
| Pfizer INC. | $24.81 | 2019 | |
| Sumitomo Pharma America, INC. | $24.59 | 2023 | Myfembree |
| Lupin INC. | $24.00 | 2019-2021 | |
| Organon LLC | $18.52 | 2023 | Nexplanon |
| Covidien LP | $17.58 | 2019 | |
| Mission Pharmacal Company | $17.17 | 2019 | |
| Trevena, INC. | $15.09 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Therapeuticsmd, INC. | $13.65 | 2021 | |
| Exeltis, USA INC. | $13.62 | 2022 | |
| Duchesnay USA Incorporated | $13.44 | 2019 | |
| Mayne Pharma Commercial LLC | $12.54 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yoram Hahn listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.